Canadian researchers have found that a generic antibiotic may reduce progression to multiple sclerosis after a person’s first demyelinating event. According to Luanne Metz, MD, of the University of Calgary and one of the study’s authors, “It’s a well-tolerated drug that requires no safety monitoring whatsoever.”
Ads by Google
Previous research has suggested that high cholesterol has a negative impact on the development of lesions in the brain of individuals with multiple sclerosis. Now a scientific team from the University of Buffalo has shed some light on how good cholesterol (high-density lipoprotein, or HDL cholesterol) may live up to its name for individuals who have this disease.
Numerous studies, including a new meta-analysis, have explored the use of whole body vibration treatment for people with multiple sclerosis. Does this nondrug, noninvasive approach have a place in an MS treatment plan?
For multiple sclerosis patients who use Betaseron, the interferon beta-1b prescription drug designed to reduce relapses in individuals with relapsing-remitting MS, a new delivery system will be available soon in the United States. The Food and Drug Administration (FDA) has approved Bayer’s BetaConnect, the first electronic autoinjector for treating RRMS.
New research suggests that an imbalance in gut bacteria may play a role not only in the development of multiple sclerosis, but in prevention and treatment of the disease as well. The study was conducted by a team of experts from various institutions in Japan, where the number of people being diagnosed with MS has been growing.
Jay Contrastano enjoyed playing golf, but when his multiple sclerosis took a turn for the worse, he thought his golfing days were over. That’s when he was introduced to an assistive device that changed his life for the better,
Why symptoms of multiple sclerosis tend to improve in the winter and get worse in the summer has puzzled experts and patients and prompted a number of speculations. Now a team of researchers has offered a new explanation that involves melatonin, which could lead to better treatment opportunities for people with MS.
It likely comes as no surprise that smoking is not good for people who have multiple sclerosis, but what may be news is how smoking impacts disease progression. A new study from Karolinska Institutet explains the effects of smoking on MS and is believed to be the first one to provide evidence of what happens when MS patients quit smoking, while another recent study also reveals news about smoking and MS prognosis.
Hearing problems are not a common symptom of multiple sclerosis. That’s good news. However, for approximately 4 to 6 percent of individuals with MS, hearing challenges are a reality that can have an impact on their quality of life, although the other good news is that most patients recover completely.
An international team of researchers recently reported on the results of the extension of a trial comparing fingolimod and interferon beta-1a in relapsing-remitting multiple sclerosis. Basically, patients fared better when they took fingolimod, but it’s worth examining the details.
Exercise may have a significant impact on multiple sclerosis in children, according to a new study. The findings, which appear in the online issue of Neurology, could be important for the estimated 10,000 children in the United States and the many thousands of others around the world who have multiple sclerosis.
The role of vitamin D in multiple sclerosis, especially related to relapse rate and disease progression, was the subject of a recent study conducted by a team from Australia. The findings shed light on the association between exposure to the sun, supplementation with vitamin D, and latitude on people with multiple sclerosis.
Two cases of progressive multifocal leukoencephalopathy (PML) associated with the use of fingolimod (Gilenya) in individuals with relapsing-remitting multiple sclerosis have been reported by the Food and Drug Administration (FDA). In both cases—one probable and one definite--the individuals had not been treated previously with another immunosuppressant drug for MS.
Massage for multiple sclerosis is not a cure, but it can provide significant benefits without the risk of drug side effects. In fact, the authors of numerous studies have reported on the advantages of this complementary therapy for MS patients.
Some individuals who have multiple sclerosis have thought about or are interested in participating in clinical trials. For those who fall into these categories and who would like some assistance, there is a Clinical Trial Notification Program that can let you know about multiple sclerosis clinical trials for which you may qualify.
For people with multiple sclerosis who choose to take medications, identifying which one or ones will be effective is a challenge and often discouraging. Now a team in Italy has discovered a specific gene mutation that may eventually help bring personalized medicine to multiple sclerosis patients.
Of the many natural treatment approaches to multiple sclerosis, the Wahls Protocol, which includes a diet and lifestyle program designed to support brain cell function, has attracted special attention in part because it was developed by a physician who has MS. Another reason is that many people who have tried it say it works, but not everyone agrees.
A new study that will evaluate the effectiveness of an experimental oral drug (RPC1063) and Avonex (interferon beta-1a) in individuals with relapsing multiple sclerosis is now recruiting participants. The effort, which is known as the Sunbeam Study, is funded by Receptos, Inc., which makes the experimental drug.
The question about the relationship between prolactin and multiple sclerosis is one that numerous researchers have been trying to answer. What do we know about the potential benefits or disadvantages of this hormone when it comes to MS?
A 20-minute documentary on multiple sclerosis, entitled simply “SM” (the original title in Polish) offers a poignant look at the lives, thoughts, and goals of three people with the disease. The two women and one man, who range in age from 20 to 61, demonstrate the universality of the determination, hope, and challenges of the disease.
Two recent studies offer some important information on bone health for individuals who have multiple sclerosis. If you have MS and haven’t had a talk with your doctor about osteoporosis and your bones, it’s high time you did.
Although most people associate a hug with something pleasant and loving, an MS hug doesn’t fit that definition. The MS hug is a common but not always well-known symptom of multiple sclerosis, especially among individuals who have a recent diagnosis.
Trigeminal neuralgia, also known as tic douloureux, is an extremely painful nerve disorder that occurs in about 3 to 4 percent of individuals who have multiple sclerosis. About 2 to 4 percent of patients with trigeminal neuralgia have MS.
Several studies have shown that hypnosis can help relieve pain associated with multiple sclerosis. If you are not satisfied with your current pain relief program or you want to try a natural approach that eliminates the risk of side effects from drugs, then hypnosis training may be for you.
A small study conducted by researchers at Marquette University in Milwaukee found that ballroom dancing may help improve function in patients with multiple sclerosis (MS).
A recent study suggests there is an association between multiple sclerosis and celiac disease that involves nerve damage. Although on the surface the relationship between these two diseases may not be obvious, closer examination makes it clearer.
Some people turn to acupuncture for multiple sclerosis, but use of this alternative or complementary treatment choice is not well studied. Here’s what a recent review and an additional study have to say about the use of acupuncture for relief of MS symptoms. Please feel free to share your experiences!